![Pieter Jaap Gaillard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter Jaap Gaillard
Founder at Mireca Medicines GmbH
Profile
Pieter Jaap Gaillard was the founder of to-BBB technologies BV, founded in 2003, where he held the title of Chief Scientific Officer.
He is also the founder of Mireca Medicines GmbH, founded in 2017, where he currently holds the title of Chairman-Supervisory Board.
Dr. Gaillard has a doctorate degree from the University of Leiden and a graduate degree from the University of Utrecht.
Pieter Jaap Gaillard active positions
Companies | Position | Start |
---|---|---|
Mireca Medicines GmbH
![]() Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Founder | 2016-12-31 |
Former positions of Pieter Jaap Gaillard
Companies | Position | End |
---|---|---|
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Founder | - |
Training of Pieter Jaap Gaillard
University of Utrecht | Graduate Degree |
University of Leiden | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
to-BBB technologies BV
![]() to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Mireca Medicines GmbH
![]() Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen, | Health Technology |
- Stock Market
- Insiders
- Pieter Jaap Gaillard